Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jinghui Lin, Meifang Li, Shijie Chen, Lihong Weng & Zhiyong He. (2021) Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial. Journal of Inflammation Research 14, pages 2557-2567.
Read now
Read now
Cheng Chen, Yan Wu, Bao Ling Liu, Hong Wei Wang, Jian Hua Ma & Ju Ying Zhou. (2020) Whole-Brain Radiotherapy Can Improve the Survival of Patients with Multiple Brain Metastases from Non-Small Cell Lung Cancer Treated by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer Management and Research 12, pages 11333-11340.
Read now
Read now
Articles from other publishers (22)
Mustafa Khasraw, Priyanka Yalamanchili, Anu Santhanagopal, Chuntao Wu, Maribel Salas, Jie Meng, Maha Karnoub, Stephen Esker & Enriqueta Felip. (2024) Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review. Advances in Therapy.
Crossref
Crossref
Alexander Spektor, Veena Venkatachalam & Kate Martin. 2024. Palliative Radiation Oncology. Palliative Radiation Oncology
99
126
.
Yaowen Song, Shuiyu Lin, Jun Chen & Jun Dang. (2023) First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis. BMC Cancer 23:1.
Crossref
Crossref
Ai Seon Kuan, Chi-Lu Chiang, Hsiu-Mei Wu, Huai-Che Yang, Ching-Jen Chen, Chung-Jung Lin, Wan-Yuo Guo, David Hung-Chi Pan, Wen-Yuh Chung & Cheng-Chia Lee. (2023) Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses. Journal of Neuro-Oncology 164:3, pages 729-739.
Crossref
Crossref
Vineeth Tatineni, Patrick J. O’Shea, Shreya Saxena, Atulya A. Khosla, Ahmad Ozair, Rupesh R. Kotecha, Xuefei Jia, Yasmeen Rauf, Erin S. Murphy, Samuel T. Chao, John H. Suh, David M. Peereboom & Manmeet S. Ahluwalia. (2023) Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study. Cancers 15:11, pages 3015.
Crossref
Crossref
Yaoshuai Zhang, Yongping Li, Yuehua Han, Min Li, Xian Li, Fangtian Fan, Hao Liu & Shanshan Li. (2023) Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor. European Journal of Pharmacology 945, pages 175571.
Crossref
Crossref
Feryal KARACA, Selahattin MENTEŞ, Ali ARSLAN, Mustafa Emre SARAÇ, Sıddık KESKİN & Timuçin ÇİL. (2023) Our Radiotherapy Results in Patients with Primary Non-Small Cell Lung Cancer with Brain MetastasesPrimeri Küçük Hücreli Dışı Akciğer Kanseri Olan Beyin Metastazlı Hastalarda Radyoterapi Sonuçlarımız. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi 18:1, pages 1-8.
Crossref
Crossref
Guangchuan Deng, Xiaojing Tan, Yankang Li, Yingyun Zhang, Qi Wang, Jianbin Li & Zhenxiang Li. (2023) Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis. Frontiers in Oncology 13.
Crossref
Crossref
Francesco Marampon, Alain J Gelibter, Pier Rodolfo Cicco, Martina Parisi, Maria Serpone, Francesca De Felice, Nadia Bulzonetti, Daniela Musio, Enrico Cortesi & Vincenzo Tombolini. (2022) Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review. BJR|case reports 8:5.
Crossref
Crossref
Jinfeng Cui, Li Li & Shuanghu Yuan. (2022) The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation. Frontiers in Oncology 12.
Crossref
Crossref
Masoumeh Najafi, Amin Jahanbakhshi, Marzieh Gomar, Cinzia Iotti, Lucia Giaccherini, Omid Rezaie, Francesco Cavallieri, Letizia Deantonio, Lilia Bardoscia, Andrea Botti, Angela Sardaro, Salvatore Cozzi & Patrizia Ciammella. (2022) State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis. Current Oncology 29:5, pages 2995-3012.
Crossref
Crossref
Yueli Shi, Yun Xu, Zhiyong Xu, Huan Wang, Jingnan Zhang, Yuan Wu, Bufu Tang, Shenfei Zheng & Kai Wang. (2022) TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. Cancer Letters 532, pages 215583.
Crossref
Crossref
Yangchun Gu, Yan Xu, Hongqing Zhuang, Weijuan Jiang, Hua Zhang, Xiaofeng Li, Yonggang Liu, Li Ma, Dahai Zhao, Yuan Cheng, Yan Yu, Ping Liu, Jianwen Qin, Xueqin Chen, Junzhen Gao, Mengzhao Wang, Li Liang & Baoshan Cao. (2021)
Value and significance of brain radiation therapy during first‐line
EGFR‐TKI
treatment in lung adenocarcinoma with
EGFR
sensitive mutation and synchronous brain metastasis: Appropriate timing and technique
. Thoracic Cancer 12:23, pages 3157-3168.
Crossref
Crossref
Fan Yu, Jianjiao Ni, Wanqin Zeng, Yue Zhou, Tiantian Guo, Ya Zeng, Yang Zhao, Shuyan Li, Yida Li, Xi Yang, Liqing Zou, Shengping Wang, Quan Liu, Yuan Li, Li Chu, Xiao Chu, Luxi Ye, Wen Yu & Zhengfei Zhu. (2021) Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer With Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 111:3, pages 804-815.
Crossref
Crossref
Bailong Liu, Hui Liu, Yunfei Ma, Qiuhui Ding, Min Zhang, Xinliang Liu & Min Liu. (2021) EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?. Cancer Medicine 10:18, pages 6167-6188.
Crossref
Crossref
Lihui Liu, Hua Bai, Samuel Seery, Sini Li, Chao Wang, Pei Xue, Jie Zhao & Jie Wang. (2021) Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis. Lung Cancer 158, pages 74-84.
Crossref
Crossref
R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allgäuer, L. König, K. Lang, T. Forster, N. Arians, S. Rieken, C.-P. Heussel, F.J. Herth, M. Thomas, A. Stenzinger, J. Debus & P. Christopoulos. (2021) Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer. ESMO Open 6:3, pages 100161.
Crossref
Crossref
Simon Page, Charlotte Milner-Watts, Marco Perna, Urska Janzic, Natalia Vidal, Naila Kaudeer, Merina Ahmed, Fiona McDonald, Imogen Locke, Anna Minchom, Jaishree Bhosle, Liam Welsh & Mary O'Brien. (2020) Systemic treatment of brain metastases in non-small cell lung cancer. European Journal of Cancer 132, pages 187-198.
Crossref
Crossref
O. Molinier, F. Goupil, D. Debieuvre, J.-B. Auliac, S. Jeandeau, S. Lacroix, F. Martin & M. Grivaux. (2020) Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients. Respiratory Medicine and Research 77, pages 46-54.
Crossref
Crossref
Shun Yao, Feifei Shi, Yingying Wang, Xiaoyang Sun, Wenbo Sun, Yifeng Zhang, Xianfang Liu, Xiangguo Liu & Ling Su. (2019) Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells. Cellular Signalling 61, pages 10-19.
Crossref
Crossref
Chen, Lee, Chuang, Hung, Huang & Chong. (2019) Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers 11:8, pages 1092.
Crossref
Crossref
Bin Yang, Qing gen Wang, Mengjie Lu, Yingqian Ge, Yu jun Zheng, Hong Zhu & Guangming Lu. (2019) Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma. Frontiers in Oncology 9.
Crossref
Crossref